INTOX Home Page
HEXYLAMINE ICSC: 1443
Date of Peer Review: October 2002

n-Hexylamine
1-Hexanamine
1-Aminohexane
CAS # 111-26-2 C6H15N / CH3(CH2)5NH2
RTECS # MQ454000 Molecular mass: 101.19
UN # 2734
EC #
TYPES OF HAZARD / EXPOSURE ACUTE HAZARDS / SYMPTOMS PREVENTION FIRST AID / FIRE FIGHTING
FIRE Flammable. Gives off irritating or toxic fumes (or gases) in a fire.
NO open flames, NO sparks, and NO smoking.
Powder, alcohol-resistant foam, water spray, carbon dioxide.
EXPLOSION Above 29C explosive vapour/air mixtures may be formed.
Above 29C use a closed system, ventilation, and explosion-proof electrical equipment.
In case of fire: keep drums, etc., cool by spraying with water.
EXPOSURE
PREVENT GENERATION OF MISTS! AVOID ALL CONTACT!
IN ALL CASES CONSULT A DOCTOR!
Inhalation Burning sensation. Cough. Sore throat. Laboured breathing. Shortness of breath. Symptoms may be delayed (see Notes).
Ventilation, local exhaust, or breathing protection.
Fresh air, rest. Half-upright position. Artificial respiration may be needed. Refer for medical attention.
Skin Redness. Pain. Skin burns.
Protective gloves. Protective clothing.
First rinse with plenty of water, then remove contaminated clothes and rinse again. Refer for medical attention.
Eyes Redness. Pain. Severe deep burns.
Face shield, or eye protection in combination with breathing protection.
First rinse with plenty of water for several minutes (remove contact lenses if easily possible), then take to a doctor.
Ingestion Burning sensation. Abdominal pain. Shock or collapse.
Do not eat, drink, or smoke during work.
Rinse mouth. Give plenty of water to drink. Do NOT induce vomiting. Refer for medical attention.
SPILLAGE DISPOSAL PACKAGING & LABELLING
Remove all ignition sources. Collect leaking and spilled liquid in sealable containers as far as possible. Absorb remaining liquid in sand or inert absorbent and remove to safe place. Wash away remainder with plenty of water. Do NOT wash away into sewer. Do NOT let this chemical enter the environment. (Extra personal protection: complete protective clothing including self-contained breathing apparatus.)
EU Classification
UN Classification
UN Hazard Class: 3
UN Subsidiary Risks: 8
UN Pack Group: II
EMERGENCY RESPONSE STORAGE
NFPA Code: H3; F3; R0;
Transport Emergency Card: TEC (R)-80GCF1-II
Fireproof. Separated from strong oxidants, strong acids.
IPCS
International
Programme on
Chemical Safety
Prepared in the context of cooperation between the International Programme on Chemical Safety and the Commission of the European Communities IPCS, CEC 1999

SEE IMPORTANT INFORMATION ON BACK


HEXYLAMINE ICSC: 1443
IMPORTANT DATA
PHYSICAL STATE; APPEARANCE:
COLOURLESS LIQUID

CHEMICAL DANGERS:
The substance decomposes on heating producing toxic fumes including nitrogen oxides. Reacts violently with oxidants causing fire and explosion hazard. The substance is a medium strong base.

OCCUPATIONAL EXPOSURE LIMITS:
TLV not established.
ROUTES OF EXPOSURE:
The substance can be absorbed into the body by inhalation, through the skin and by ingestion.

INHALATION RISK:
No indication can be given about the rate in which a harmful concentration in the air is reached on evaporation of this substance at 20C.

EFFECTS OF SHORT-TERM EXPOSURE:
The substance is corrosive to the eyes, the skin and the respiratory tract. Corrosive on ingestion. Inhalation may cause lung oedema (see Notes). The effects may be delayed. Medical observation is indicated.

PHYSICAL PROPERTIES
Boiling point: 131-132C
Melting point: -22.9C
Relative density (water = 1): 0.77
Solubility in water, g/100 ml: 1.2
Vapour pressure, kPa at 20C: 0.87
Relative vapour density (air = 1): 3.5
Relative density of the vapour/air-mixture at 20C (air = 1): 1.02
Flash point: 29C o.c.
Octanol/water partition coefficient as log Pow: 1.52/2.34
ENVIRONMENTAL DATA
The substance is toxic to aquatic organisms. It is strongly advised that this substance does not enter the environment.
NOTES
The symptoms of lung oedema often do not become manifest until a few hours have passed and they are aggravated by physical effort. Rest and medical observation is therefore essential. Immediate administration of an appropriate inhalation therapy by a doctor or a person authorized by him/her, should be considered.
ADDITIONAL INFORMATION


LEGAL NOTICE Neither the CEC nor the IPCS nor any person acting on behalf of the CEC or the IPCS is responsible for the use which might be made of this information
IPCS, CEC 1999